China Pharma Holdings (CPHI) Interest Expenses (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Interest Expenses came in at $15758.0 in Q1 2026, down 43.78% YoY from $28028.0 in Q1 2025, and little changed on a QoQ basis from $15725.0 in Q4 2025.
China Pharma Holdings (CPHI) Interest Expenses (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Interest Expenses data on file, last reported at $15758.0 in Q1 2026.
- Quarterly Interest Expenses fell 43.78% year-over-year to $15758.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79524.0 (up 22.54% YoY) and the FY2025 annual result came in at $11.9 million, up 2281.42% from the prior year.
- Interest Expenses held at $15758.0 in Q1 2026, from $15725.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $21.8 million in Q3 2023 to a low of -$252776.0 in Q4 2023.
- A 5-year average of $1.3 million and a median of $21061.0 in 2024 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 108634.93% in 2023, down 592.77% in 2023.
- Tracing CPHI's Interest Expenses over 5 years: stood at $51297.0 in 2022, then sank by 592.77% to -$252776.0 in 2023, then jumped by 98.29% to -$4333.0 in 2024, then surged by 462.91% to $15725.0 in 2025, then grew by 0.21% to $15758.0 in 2026.
- The last three Interest Expenses figures came in at $15758.0 (Q1 2026), $15725.0 (Q4 2025), and $207135.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | 26,359.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,758.00 |
| Mar 31, 2026 | 15,758.00 |
| Dec 31, 2025 | 15,725.00 |
| Dec 31, 2025 | 15,725.00 |
| Sep 30, 2025 | 207,135.00 |
| Sep 30, 2025 | 207,135.00 |
| Jun 30, 2025 | 20,013.00 |
| Jun 30, 2025 | 20,013.00 |
| Mar 31, 2025 | 28,028.00 |
| Mar 31, 2025 | 28,028.00 |
| Dec 31, 2024 | -4,333.00 |
| Dec 31, 2024 | -4,333.00 |
| Sep 30, 2024 | 21,061.00 |
| Sep 30, 2024 | 21,061.00 |
| Jun 30, 2024 | 20,142.00 |
| Jun 30, 2024 | 20,142.00 |
| Mar 31, 2024 | 22,928.00 |
| Mar 31, 2024 | 22,928.00 |
| Dec 31, 2023 | -252,776.00 |
| Dec 31, 2023 | -252,776.00 |